Institutional Exposure To Novavax, Inc. (NVAX)

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $12.68, with 6.04 million shares of worth about $76.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 197.65% during that period and on October 09, 2024 the price saw a loss […]

Is Novavax, Inc. (NASDAQ: NVAX) Back In The Buying Zone?

Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of -7.30% and -5.01% over the past three months. NVAX shares are trading 156.67% year to date (YTD), with the 12-month market performance up to 70.17% higher. […]

Do Novavax, Inc. (NASDAQ: NVAX) Fit In A Value Investing Philosophy?

Currently, there are 160.09M common shares owned by the public and among those 153.03M shares have been available to trade. The company’s stock has a 5-day price change of 2.78% and -5.07% over the past three months. NVAX shares are trading 176.87% year to date (YTD), with the 12-month market performance up to 86.40% higher. […]

Novavax, Inc. (NASDAQ: NVAX) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]

An Important Check-Up On Novavax, Inc. (NASDAQ: NVAX)

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $3.98, with 4.81 million shares of worth about $19.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -50.68% during that period and on Wednesday the price saw a loss of about […]

Novavax, Inc. (NASDAQ: NVAX) Has Another Chance To Impress You

Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]

Novavax, Inc. (NASDAQ: NVAX): Hunting Genuine Value In Market Debris

Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]

Value Hunters: Look To Novavax, Inc. (NVAX)

SSgA Funds Management, Inc. recently announced the acquisition of new stake in Novavax, Inc. (NASDAQ:NVAX). The institutional investor has increased its shareholding in the Healthcare company by 43.32% to 14.58 million shares with purchase of 4.41 million shares. This fresh investment now brings its stake to 12.28% valued currently at $70.0 million. In addition, The […]

Analyst Expect Big Moves From Novavax, Inc. (NASDAQ: NVAX)

The Vanguard Group, Inc. recently announced the acquisition of new stake in Novavax, Inc. (NASDAQ:NVAX). The institutional investor has increased its shareholding in the Healthcare company by 9.57% to 11.32 million shares with purchase of 0.99 million shares. This fresh investment now brings its stake to 9.53% valued currently at $54.36 million. In addition, Shah […]

Stick With Novavax, Inc. (NVAX). The Bull Are Alive And Well

With over 8.88 million Novavax, Inc. (NVAX) shares trading Monday and a closing price of $5.15 on the day, the dollar volume was approximately $45.72 million. The shares have shown a negative half year performance of -44.98% and its price on 01/08/24 gained nearly 3.00%. Currently, there are 118.79M common shares owned by the public […]